The prognostic value of cyclin D1 in renal cell carcinoma

International Urology and Nephrology

Volumn 46, Issue 5, 2014, Pages 905-913

  Lima, M S ^a   Pereira, R A ^a   Costa, R S ^a   Tucci, S ^a   Dantas, M ^a   Muglia, V F ^a   Ravinal, R C ^a   Barros Silva, G E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Clear cell renal cell carcinoma; Cyclin D1; Prognostic factors; Renal cell carcinoma

Indexed keywords

CYCLIN D1; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY NECROSIS; KIDNEY PARENCHYMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; SARCOMATOID CARCINOMA; SYMPTOM; VON HIPPEL LINDAU DISEASE; CANCER GRADING; CHEMISTRY; KIDNEY; KIDNEY TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; SECONDARY; SURVIVAL RATE; TUMOR VOLUME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOMA, RENAL CELL; CHILD; CYCLIN D1; FEMALE; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL RATE; TUMOR BURDEN; YOUNG ADULT;

EID: 84894032846     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-013-0602-0     Document Type: Article

References (20)

1. Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) (2004) Pathology and genetics of tumours of the urinary system and male genital organs. World Health Organization Classification of Tumours. IARC Press, International Agency for Research on Cancer, Lyon, France
2. Lindblad P (2004) Epidemiology of renal cell carcinoma. Scand J Surg 93(2):88-96
3. Chow W-H, Dong LM, Devessa SS (2010) Epidemiology and risk factors for kidney cancer. Nat Rev Urol 7(5):245-257
4. Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z (2006) 2004 WHO classification of the renal tumors of the adults. Eur Urol 49(5):798-805
5. Volpe A, Patard JJ (2010) Prognostic factors in renal cell carcinoma. World J Urol 28(3):319-327
6. Furniss D, Harnden P, Ali N et al (2008) Prognostic factors for renal cell carcinoma. Cancer Treat Rev 34(5):407-426
7. Donnellan R, Chetty R (1998) Cyclin D1 and human neoplasia. Mol Pathol 51(1):1-7 (Pubitemid 28157349)
8. Stamatakos M, Palla V, Karaiskos I et al (2010) Cell cyclins: triggering elements of cancer or not? World J Surg Oncol 8:111
9. Diehl JA (2002) Cycling to cancer with cyclin D1. Cancer Biol Ther 1(3):226-231
10. Kim JK, Diehl JA (2009) Nuclear cyclin D1: na oncogenic driver in human cancer. J Cell Physiol 220(2):292-296
11. Zhu J, Yu L, Zhan P et al (2010) The relationships between cyclin D1 expression and prognosis of non-small cell lung cancer. Chin J Lung Cancer 13(8):803-808
12. Gillett C, Smith P, Gregory W et al (1996) Cyclin D1 and prognosis in human breast cancer. Int J Cancer 69(2):92-99 (Pubitemid 26167163)
13. Hedberg Y, Davoodi E, Roos G et al (1999) Cyclin-D1 expression in human renal-cell carcinoma. Int J Cancer 84(3):268-272 (Pubitemid 29256753)
14. Hedberg Y, Ljungberg B, Roos G, Landgerg G (2003) Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray. Br J Cancer 88(9):1417-1423 (Pubitemid 36606426)
15. Aaltomaa S, Lipponen P, Ala-Opas M et al (1999) Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. Br J Cancer 80(12):2001-2007 (Pubitemid 29391288)
16. Migita T, Oda Y, Naito S, Tsuneyoshi M (2002) Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma. Cancer 94(4):973-979 (Pubitemid 34150851)
17. Greene FL, Page D, Morrow M, Balch C, Haller D, Fritz A, Fleming I (eds) (2002) AJCC cancer staging manual, 6th edn. Springer, New York
18. Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6(7):655-663 (Pubitemid 13234762)
19. Mueller A, Odze R, Jenkins TD et al (1997) A transgenic mouse model with cyclin D1 overexpression results in cell cycle, epidermal growth factor receptor and p53 abnormalities. Cancer Res 57:5542-5549 (Pubitemid 28006762)
20. Hedberg Y, Ljungberg B, Roos G, Landgerg G (2004) Retinoblastoma protein in human renal cell carcinoma in relation to alterations in G1/S regulatory proteins. Int J Cancer 109:189-193 (Pubitemid 38240919)